Literature DB >> 11981477

[Sweet's syndrome and erythema nodosum associated with Crohn's disease treated by infliximab].

Geoffroy Vanbiervliet, Rodolphe Anty, Stéphane Schneider, Kamel Arab, Patrick Rampal, Xavier Hebuterne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981477

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


× No keyword cloud information.
  7 in total

Review 1.  Extraintestinal complications of inflammatory bowel disease.

Authors:  Tim Orchard
Journal:  Curr Gastroenterol Rep       Date:  2003-12

2.  Pustular skin lesions in patients treated with infliximab: report of two cases.

Authors:  M J F Starmans-Kool; H R M Peeters; H H M L Houben
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

Review 3.  Extraintestinal Manifestations of Inflammatory Bowel Disease.

Authors:  Stephan R Vavricka; Alain Schoepfer; Michael Scharl; Peter L Lakatos; Alexander Navarini; Gerhard Rogler
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

4.  [Sweet Syndrome: Clinical and pathologic study over 5 years].

Authors:  Hanae Bouzidi; Salim Gallouj; Nissrine Amraoui; Fatima Zahra Mernissi; Taoufiq Harmouch
Journal:  Pan Afr Med J       Date:  2015-04-14

Review 5.  Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.

Authors:  Daniela Michelle Pérez-Garza; Sonia Chavez-Alvarez; Jorge Ocampo-Candiani; Minerva Gomez-Flores
Journal:  Am J Clin Dermatol       Date:  2021-03-08       Impact factor: 7.403

Review 6.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

Review 7.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.